Article info
PDFPostScript
Letter
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis
- Correspondence to Emanuel Della-Torre, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS-San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Italy; dellatorre.emanuel{at}hsr.it
Citation
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis
Publication history
- Received May 25, 2017
- Revised July 24, 2017
- Accepted July 27, 2017
- First published August 17, 2017.
Online issue publication
March 15, 2018
Article Versions
- Previous version (17 August 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.